Amicus Therapeutics

2 followers

‌

Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.

Org chart

Bradley L. Campbell
President & CEO

Bradley L. Campbell

Collapse
David Clark
Chief People Officer
Ellen S. Rosenberg
Chief Legal Officer
Jayne C. Gershkowitz
Chief Patient Advocate
Jeffrey P. Castelli
Chief Portfolio Officer and Head of Gene Therapy
Patrik Florencio
Senior Vice President, Global Chief Compliance & Risk Officer
Julie Yu
Chief Program Officer
Jill Weimer
Chief Science Officer
Pat Osullivan
Chief Technical Operations Officer
Sam Pierre-Louis
SVP Chief Information Officer
Alastair Reed
Director, International Tax Lead
Aurelien le Thiec
Finance & Business Operations Director
Delayne Scelfo
Associate Director, Finance
Jordan Masanoff
Senior Director, Business Development & Portfolio Planning
Ron Skwirut
Tax Director
Yun Gu
Senior Fp&a Manager
Jennifer Sullivan
Accounting Manager
Kelly Phillips
Senior Manager, Global Accounts Payables
Nicholas Juenemann
Senior, Technical Accounting And Reporting